{"id":"https://openalex.org/W3215124231","doi":"https://doi.org/10.1182/blood-2021-151324","title":"Effects of Alvelestat, an Oral Neutrophil Elastase Inhibitor, on Elevated Elastase and Collagen Turnover Biomarkers in Patients with Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation","display_name":"Effects of Alvelestat, an Oral Neutrophil Elastase Inhibitor, on Elevated Elastase and Collagen Turnover Biomarkers in Patients with Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation","publication_year":2021,"publication_date":"2021-11-05","ids":{"openalex":"https://openalex.org/W3215124231","doi":"https://doi.org/10.1182/blood-2021-151324","mag":"3215124231"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2021-151324","doi":"https://doi.org/10.1182/blood-2021-151324","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-151324","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083465867","display_name":"Annie Im","orcid":"https://orcid.org/0000-0002-0973-7100","observed_orcids":["https://orcid.org/0000-0002-0973-7100"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Annie Im","raw_affiliation_strings":["UPMC Hillman Cancer Center, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UPMC Hillman Cancer Center, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078054016","display_name":"Jacqueline Parkin","orcid":"https://orcid.org/0000-0002-6449-0542","observed_orcids":["https://orcid.org/0000-0002-6449-0542"]},"institutions":[{"id":"https://openalex.org/I4405267379","display_name":"Mereo BioPharma Group PLC (United Kingdom)","ror":"https://ror.org/02g73z327","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405267379"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jacqueline Parkin","raw_affiliation_strings":["Mereo BioPharma Group, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mereo BioPharma Group, London, United Kingdom","institution_ids":["https://openalex.org/I4405267379"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083948602","display_name":"Noa G. Holtzman","orcid":"https://orcid.org/0000-0002-5706-1109","observed_orcids":["https://orcid.org/0000-0002-5706-1109"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Noa G. Holtzman","raw_affiliation_strings":["Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":null,"display_name":"William Moore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267379","display_name":"Mereo BioPharma Group PLC (United Kingdom)","ror":"https://ror.org/02g73z327","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405267379"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"William Moore","raw_affiliation_strings":["Mereo BioPharma Group, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mereo BioPharma Group, London, United Kingdom","institution_ids":["https://openalex.org/I4405267379"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104521377","display_name":"Lauren M. Curtis","orcid":"https://orcid.org/0000-0003-4129-0334","observed_orcids":["https://orcid.org/0000-0003-4129-0334","https://orcid.org/0000-0002-3805-3170"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]},{"id":"https://openalex.org/I4210148073","display_name":"Sibley Memorial Hospital","ror":"https://ror.org/056jn9s46","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210148073"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lauren M. Curtis","raw_affiliation_strings":["Sibley Memorial Hospital, Sidney Kimmel Cancer Center, Johns Hopkins Medicine, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sibley Memorial Hospital, Sidney Kimmel Cancer Center, Johns Hopkins Medicine, Washington, DC","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436","https://openalex.org/I4210148073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021815921","display_name":"Cody J. Peer","orcid":"https://orcid.org/0000-0001-9395-3473","observed_orcids":["https://orcid.org/0000-0001-9395-3473"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cody Peer","raw_affiliation_strings":["Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001321994","display_name":"William D. Figg","orcid":"https://orcid.org/0000-0002-5875-2606","observed_orcids":["https://orcid.org/0000-0002-5875-2606","https://orcid.org/0000-0003-2428-5613"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William D. Figg","raw_affiliation_strings":["Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003258570","display_name":"Jeremy J. Rose","orcid":"https://orcid.org/0000-0001-8859-041X","observed_orcids":["https://orcid.org/0000-0001-8859-041X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeremy J. Rose","raw_affiliation_strings":["Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067464367","display_name":"Laura Parsons-Wandell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Parsons-Wandell","raw_affiliation_strings":["Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062706815","display_name":"Frances T. Hakim","orcid":"https://orcid.org/0000-0003-2507-8229","observed_orcids":["https://orcid.org/0000-0003-2507-8229"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frances T. Hakim","raw_affiliation_strings":["Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065897197","display_name":"Steven Zivko Pavletic","orcid":"https://orcid.org/0000-0001-9111-9354","observed_orcids":["https://orcid.org/0000-0001-9111-9354"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Z. Pavletic","raw_affiliation_strings":["National Cancer Institute, Center for Cancer Research, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute, Center for Cancer Research, Bethesda, MD","institution_ids":["https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"138","issue":"Supplement 1","first_page":"1815","last_page":"1815"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9545999765396118,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9545999765396118,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11189","display_name":"Transplantation: Methods and Outcomes","score":0.028699999675154686,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bronchiolitis-obliterans-syndrome","display_name":"bronchiolitis obliterans syndrome","score":0.9509999752044678},{"id":"https://openalex.org/keywords/neutrophil-elastase-inhibitor","display_name":"neutrophil elastase inhibitor","score":0.9459999799728394},{"id":"https://openalex.org/keywords/chronic-graft-versus-host-disease","display_name":"chronic graft-versus-host disease","score":0.8650000095367432},{"id":"https://openalex.org/keywords/hematopoietic-stem-cell-transplantation","display_name":"hematopoietic stem cell transplantation","score":0.9580000042915344},{"id":"https://openalex.org/keywords/airway-neutrophilia","display_name":"airway neutrophilia","score":0.8220000267028809},{"id":"https://openalex.org/keywords/pro-c3","display_name":"PRO-C3","score":0.8080000281333923},{"id":"https://openalex.org/keywords/pro-c6","display_name":"PRO-C6","score":0.9779999852180481},{"id":"https://openalex.org/keywords/c3m","display_name":"C3M","score":0.7390000224113464},{"id":"https://openalex.org/keywords/airway-fibrosis","display_name":"airway fibrosis","score":0.796999990940094},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5120000243186951},{"id":"https://openalex.org/keywords/biomarker-response","display_name":"biomarker response","score":0.3310000002384186}],"concepts":[{"id":"https://openalex.org/C2776739411","wikidata":"https://www.wikidata.org/wiki/Q614750","display_name":"Bronchiolitis obliterans","level":4,"score":0.8649916052818298},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7318627834320068},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5243404507637024},{"id":"https://openalex.org/C2776317360","wikidata":"https://www.wikidata.org/wiki/Q14905648","display_name":"Neutrophil elastase","level":3,"score":0.5192399024963379},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5087528824806213},{"id":"https://openalex.org/C2777802486","wikidata":"https://www.wikidata.org/wiki/Q491741","display_name":"Neutrophilia","level":2,"score":0.5084956884384155},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.506166398525238},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4830499291419983},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38794755935668945},{"id":"https://openalex.org/C2781448352","wikidata":"https://www.wikidata.org/wiki/Q1637912","display_name":"Lung transplantation","level":3,"score":0.37953874468803406},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.11224454641342163}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2021-151324","doi":"https://doi.org/10.1182/blood-2021-151324","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-151324","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8799999952316284}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2096722196","https://openalex.org/W2036915786","https://openalex.org/W2042577913","https://openalex.org/W1997430425","https://openalex.org/W1989080740","https://openalex.org/W162331040","https://openalex.org/W2028865642","https://openalex.org/W2118384216","https://openalex.org/W2059654686","https://openalex.org/W2774903098"],"abstract_inverted_index":{"Abstract":[0],"Introduction":[1],"Bronchiolitis":[2],"Obliterans":[3],"Syndrome":[4],"(BOS)":[5],"is":[6,24,33,48,63,511,573],"a":[7,27,34,49,78,172,373,449],"rare":[8],"but":[9],"devastating":[10],"complication":[11],"of":[12,36,51,57,73,82,115,134,182,220,300,316,344,351,382,448,454,462,467,484,515,543,550,563,566,615],"chronic":[13,145,529,586],"graft-versus-host":[14],"disease":[15,474],"(GVHD)":[16],"after":[17,92,147,296],"allogeneic":[18],"hematopoietic":[19],"cell":[20],"transplantation":[21],"(HCT)":[22],"and":[23,30,41,59,103,119,123,125,128,144,204,216,259,274,282,290,417,425,432,457,501,528,554,565,585],"associated":[25,539],"with":[26,90,142,342,403,427,526,532,540],"high":[28],"morbidity":[29],"mortality.":[31],"There":[32,434,445],"dearth":[35],"treatment":[37,429,485,572],"options":[38],"for":[39,177,575,603],"BOS":[40,91,143,527,584],"new":[42],"strategies":[43],"are":[44,76,130,270],"needed.":[45],"Airway":[46],"neutrophilia":[47],"hallmark":[50],"BOS,":[52],"even":[53],"in":[54,70,88,439,460,478,524,583],"the":[55,71,97,152,218,320,348,360,399,512,533],"absence":[56],"infection,":[58],"neutrophil":[60,105,244,557],"elastase":[61,106,245,392,455,517,558,564],"(NE)":[62],"an":[64,83],"enzyme":[65],"that":[66,175],"has":[67],"been":[68],"implicated":[69],"pathogenesis":[72],"BOS.":[74],"We":[75],"conducting":[77],"phase":[79,159],"1b":[80],"study":[81,161],"oral":[84],"NE":[85,111,491,535],"inhibitor,":[86,536],"alvelestat,":[87],"patients":[89,285,309,525],"HCT":[93,148],".":[94],"Biomarkers,":[95],"including":[96],"elastin":[98,498,522],"breakdown":[99,523],"peptides":[100],"desmosine/isodesmosine":[101],"(DES/IDES),":[102],"stimulated":[104,243,391,556],"assess":[107],"direct":[108],"effect":[109,451],"on":[110,452],"activity.":[112,559],"Neo-epitope":[113],"by-products":[114],"collagen":[116,440,458,567],"type":[117],"3":[118],"6":[120,180,343,461],"synthesis":[121,412],"(PRO-C3":[122],"PRO-C6)":[124],"degradation":[126,441],"(C3M":[127],"C6M)":[129,444],"measured":[131,227,248,262,414],"as":[132,272,413,519],"biomarkers":[133,442,453,569],"fibrosis/tissue":[135],"modelling":[136],"Methods":[137],"Patients":[138],"age":[139],"\u226518":[140],"years":[141],"GVHD":[146],"were":[149,212,261,286,310,329],"recruited":[150],"to":[151,179,197,312,319,364,488,497,578],"National":[153,608,613],"Cancer":[154,604,609],"Institute":[155],"protocol":[156],"(NCT02669251).":[157],"This":[158,510],"1":[160,295],"had":[162,469],"2":[163,195],"parts:":[164],"8-week":[165],"intra-patient":[166],"dose":[167,314,322,361,400,552],"escalation":[168,315,362,401,553],"period,":[169,402],"followed":[170],"by":[171,228,249,263,369,415,521],"continuation":[173],"period":[174,363],"allowed":[176],"up":[178,318],"months":[181],"treatment.":[183],"Alvelestat":[184],"was":[185,226,247,302,333,419,435,446,538],"given":[186],"orally":[187],"starting":[188],"at":[189,214,217,298,335,423,482],"60mg":[190],"twice":[191,199,202,207,324],"daily,":[192,200,203],"increased":[193,420],"every":[194],"weeks":[196,549],"120mg":[198],"180mg":[201],"finally":[205],"240mg":[206,323],"daily.":[208,325],"Peripheral":[209],"blood":[210],"samples":[211],"collected":[213],"baseline":[215,336,380,424],"end":[219,483],"each":[221],"dose-escalation":[222],"stage.":[223],"Plasma":[224],"DES/IDES":[225,332],"isotopic":[229],"dilution":[230],"liquid":[231],"chromatography-tandem":[232],"mass":[233],"spectrometry":[234],"(Huang":[235],"et":[236],"al":[237],"Thorax":[238],"2012;67:502-508).":[239],"Ex":[240,388],"vivo":[241,389],"zymosan":[242,390],"activity":[246,393,456,518],"ProteaseTag\u00ae":[250],"immunoassay":[251],"(ProAxsis":[252],"Ltd,":[253],"Northern":[254],"Ireland).":[255],"PRO-C3,":[256],"PRO-C6,":[257],"C3M":[258],"C6M":[260],"competitive":[264],"ELISA.":[265],"(Nordic":[266],"Biosciences,":[267],"Denmark).":[268],"Results":[269,279],"presented":[271],"Mean":[273,277],"Standard":[275],"Error":[276],"(SEM).":[278],"Between":[280],"2016":[281],"2018,":[283],"7":[284,308,345,463],"enrolled":[287],"(3":[288],"men":[289],"4":[291],"women).":[292],"Median":[293],"FEV":[294],"bronchodilator":[297],"time":[299],"enrollment":[301],"44%":[303],"predicted":[304,481],"(range":[305],"38-74).":[306],"All":[307],"able":[311],"tolerate":[313],"alvelestat":[317,428,537,571],"maximum":[321],"Preliminary":[326],"clinical":[327],"results":[328],"previously":[330],"presented.":[331],"elevated":[334,516],"(mean":[337],"0.464":[338],"(SEM":[339,366,384],"0.0508)":[340],"ng/ml,":[341],"subjects":[346,405],"above":[347,421],"Upper":[349],"Limit":[350],"Normal":[352],"(ULN,":[353],"0.280":[354],"ng/ml)).":[355],"Levels":[356],"progressively":[357],"declined":[358,426],"during":[359],"0.380":[365],"0.0419)":[367],"ng/ml":[368],"week":[370],"8,":[371],"representing":[372],"mean":[374],"within":[375],"subject":[376],"%":[377,480],"change":[378,438,477],"from":[379,476,486],"(CFB)":[381],"-16.2%":[383],"6.794,":[385],"Figure":[386],"1a)":[387],"also":[394],"showed":[395],"progressive":[396,541,580],"decrease":[397],"over":[398,547],"some":[404],"demonstrating":[406],"100%":[407],"suppression":[408,562],"(Figure":[409,430],"1b).":[410],"Collagen":[411],"PRO-C3":[416],"PRO-C6":[418],"ULN":[422],"1c":[431],"1d).":[433],"no":[436],"consistent":[437,561],"(C3M,":[443],"consistency":[447],"suppressive":[450],"turnover":[459],"treated":[464],"patients,":[465],"all":[466],"whom":[468],"improved":[470],"or":[471],"stable":[472],"lung":[473,494,581],"(ranging":[475],"FEV1":[479],"+9%":[487],"-6%).":[489],"Conclusion":[490],"can":[492],"damage":[493],"tissue":[495],"due":[496],"breakdown,":[499],"pro-inflammatory":[500],"pro-fibrotic":[502],"effects":[503],"(Sallenave":[504],"J-M,":[505],"J":[506],"Leuk":[507],"Biol":[508],"2015;98:137-139).":[509],"first":[513],"evidence":[514],"detected":[520],"GVHD.":[530,587],"Treatment":[531],"selective":[534],"reduction":[542,555],"plasma":[544],"desmosine":[545],"levels":[546],"8":[548],"within-subject":[551],"The":[560],"synthesis/turnover":[568],"following":[570],"encouraging":[574],"its":[576],"potential":[577],"impact":[579],"fibrosis":[582],"Disclosures":[588],"Parkin:":[589],"Mereo":[590,596],"BioPharma":[591,597],"Group:":[592,598],"Current":[593,599],"Employment.":[594,600],"Moore:":[595],"Pavletic:":[601],"Center":[602],"Research:":[605],"Research":[606,611,617,620,623,627,630,633],"Funding;":[607,612,618,621,624,628,631],"Institute:":[610],"Institutes":[614],"Health:":[616],"Celgene:":[619],"Actelion:":[622],"Eli":[625],"Lilly:":[626],"Pharmacyclics:":[629],"Kadmon:":[632],"Funding.":[634]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-10-10T00:00:00"}